Learn More
Medchemexpress LLC N-(1-(1H-indol-3-yl)hexan-2-yl)-2-(4-methylpiperazin-1-yl)-1,3-thiazole-5-carboxamide (racemic) | 1802518-63-3 | 99.9% | 425.59 g·mol⁻¹ | C23H31N5OS | 25MG

Supplier: Medchemexpress LLC HY12528725MG
(Rac)-Minzasolmin is a racemic small-molecule inhibitor of alpha-synuclein misfolding that penetrates the blood-brain barrier. It acts on early-stage aggregation by displacing membrane-bound oligomers, promoting reversion to monomers and reducing pathological aggregation. It is used in preclinical research to evaluate effects on alpha-synuclein deposition and neuro-pathological markers in models of Parkinson's disease and dementia with Lewy bodies.
- Racemic small-molecule inhibitor of alpha-synuclein misfolding.
- Blood-brain barrier penetrant for central nervous system studies.
- Modulates early-stage alpha-synuclein aggregation mechanisms.
- Shown to reduce alpha-synuclein deposition in preclinical models.
- Supplied as a solid with high chemical purity for laboratory use.
- Available in small-scale quantities suitable for preclinical experiments.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.